Jeri L. Bryant - Publications

Affiliations: 
Genetic Medicine Vanderbilt University, Nashville, TN 
Area:
Cerebellum, Epilepsy, SCN1A

5/140 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Roy S, Bryant JL, Cao Y, Heck DH. High-precision, three-dimensional tracking of mouse whisker movements with optical motion capture technology. Frontiers in Behavioral Neuroscience. 5: 27. PMID 21713124 DOI: 10.3389/Fnbeh.2011.00027  0.579
2010 Bryant JL, Boughter JD, Gong S, LeDoux MS, Heck DH. Cerebellar cortical output encodes temporal aspects of rhythmic licking movements and is necessary for normal licking frequency. The European Journal of Neuroscience. 32: 41-52. PMID 20597972 DOI: 10.1111/J.1460-9568.2010.07244.X  0.604
2009 Bryant JL, Roy S, Heck DH. A technique for stereotaxic recordings of neuronal activity in awake, head-restrained mice. Journal of Neuroscience Methods. 178: 75-9. PMID 19073214 DOI: 10.1016/J.Jneumeth.2008.11.014  0.6
2007 Boughter JD, Baird JP, Bryant J, St John SJ, Heck D. C57BL/6J and DBA/2J mice vary in lick rate and ingestive microstructure. Genes, Brain, and Behavior. 6: 619-27. PMID 17212649 DOI: 10.1111/J.1601-183X.2006.00293.X  0.561
2006 Hayar A, Bryant JL, Boughter JD, Heck DH. A low-cost solution to measure mouse licking in an electrophysiological setup with a standard analog-to-digital converter. Journal of Neuroscience Methods. 153: 203-7. PMID 16364450 DOI: 10.1016/J.Jneumeth.2005.10.023  0.576
Low-probability matches (unlikely to be authored by this person)
2009 June HL, Tzeng Yang AR, Bryant JL, Jones O, Royal W. Vitamin A deficiency and behavioral and motor deficits in the human immunodeficiency virus type 1 transgenic rat. Journal of Neurovirology. 15: 380-9. PMID 19995129 DOI: 10.3109/13550280903350200  0.199
1999 Mozes MM, Kopp JB, Singletary S, Bryant JL. A pharmaceutical preparation of human chorionic gonadotropin modulates transgene RNA expression and ameliorates wasting in HIV-transgenic mice Transgenics. 3: 1-10.  0.172
1986 Lacher RC, Bryant JL, Howard LN. A model for the asymptotic behavior of loop entanglement in a constrained liquid region The Journal of Chemical Physics. 85: 6147-6152.  0.171
1994 Kopp JB, Ray PE, Adler SH, Bruggeman LA, Mangurian CV, Owens JW, Eckhaus MA, Bryant JL, Klotman PE. Nephropathy in HIV-transgenic mice. Contributions to Nephrology. 107: 194-204. PMID 8004968  0.169
2002 Mozes MM, Bryant JL, Franks R, Chan CC, Kopp JB. Congenital nuclear cataracts and uveitis in HIV-transgenic mice. Eye (London, England). 16: 177-84. PMID 11988819 DOI: 10.1038/sj/EYE/6700101  0.164
2010 Isbister GK, Calver LA, Page CB, Stokes B, Bryant JL, Downes MA. Randomized controlled trial of intramuscular droperidol versus midazolam for violence and acute behavioral disturbance: the DORM study. Annals of Emergency Medicine. 56: 392-401.e1. PMID 20868907 DOI: 10.1016/j.annemergmed.2010.05.037  0.159
1996 Gill PS, Lunardi-Ishkandar Y, Louie S, Tulpule A, Zheng T, Espina BM, Besnier JM, Hermans P, Levine AM, Bryant JL, Gallo RC. The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma. The New England Journal of Medicine. 335: 1261-9. PMID 8857005 DOI: 10.1056/Nejm199610243351702  0.158
2010 Sultana S, Li H, Puche A, Jones O, Bryant JL, Royal W. Quantitation of parvalbumin+ neurons and human immunodeficiency virus type 1 (HIV-1) regulatory gene expression in the HIV-1 transgenic rat: effects of vitamin A deficiency and morphine. Journal of Neurovirology. 16: 33-40. PMID 20113193 DOI: 10.3109/13550280903555712  0.15
1993 Kopp JB, Rooney JF, Wohlenberg C, Dorfman N, Marinos NJ, Bryant JL, Katz SI, Notkins AL, Klotman PE. Cutaneous disorders and viral gene expression in HIV-1 transgenic mice. Aids Research and Human Retroviruses. 9: 267-75. PMID 8471318 DOI: 10.1089/Aid.1993.9.267  0.142
2000 Shrivastav S, Cusumano A, Kanno Y, Chen G, Bryant JL, Kopp JB. Role of T lymphocytes in renal disease in HIV-transgenic mice. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 35: 408-17. PMID 10692266  0.141
2013 Jones SC, Bryant JL, Harrison SA. Behavioral Responses of the Bed Bug to Permethrin-Impregnated ActiveGuard™ Fabric. Insects. 4: 230-40. PMID 26464388 DOI: 10.3390/insects4020230  0.14
1994 Ray PE, Bruggeman LA, Weeks BS, Kopp JB, Bryant JL, Owens JW, Notkins AL, Klotman PE. bFGF and its low affinity receptors in the pathogenesis of HIV-associated nephropathy in transgenic mice. Kidney International. 46: 759-72. PMID 7996798  0.138
1995 Franks RR, Ray PE, Babbott CC, Bryant JL, Notkins AL, Santoro TJ, Klotman PE. Maternal-fetal interactions affect growth of human immunodeficiency virus type 1 transgenic mice. Pediatric Research. 37: 56-63. PMID 7700734  0.136
2015 Jones SC, Bryant JL, Sivakoff FS. Sublethal Effects of ActiveGuard Exposure on Feeding Behavior and Fecundity of the Bed Bug (Hemiptera: Cimicidae). Journal of Medical Entomology. 52: 413-8. PMID 26334815 DOI: 10.1093/Jme/Tjv008  0.13
1999 Samaniego F, Bryant JL, Liu N, Karp JE, Sabichi AL, Thierry A, Lunardi-Iskandar Y, Gallo RC. Induction of programmed cell death in Kaposi's sarcoma cells by preparations of human chorionic gonadotropin. Journal of the National Cancer Institute. 91: 135-43. PMID 9923854 DOI: 10.1093/Jnci/91.2.135  0.126
1995 Thierry AR, Lunardi-Iskandar Y, Bryant JL, Rabinovich P, Gallo RC, Mahan LC. Systemic gene therapy: biodistribution and long-term expression of a transgene in mice. Proceedings of the National Academy of Sciences of the United States of America. 92: 9742-6. PMID 7568209 DOI: 10.1073/Pnas.92.21.9742  0.125
1992 Kopp JB, Klotman ME, Adler SH, Bruggeman LA, Dickie P, Marinos NJ, Eckhaus M, Bryant JL, Notkins AL, Klotman PE. Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes. Proceedings of the National Academy of Sciences of the United States of America. 89: 1577-81. PMID 1542649  0.125
2011 Jazaeri AA, Bryant JL, Park H, Li H, Dahiya N, Stoler MH, Ferriss JS, Dutta A. Molecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma. Neoplasia (New York, N.Y.). 13: 899-911. PMID 22028616 DOI: 10.1593/Neo.11138  0.123
2003 Yang Q, Hokland ME, Bryant JL, Zhang Y, Nannmark U, Watkins SC, Goldfarb RH, Herberman RB, Basse PH. Tumor-localization by adoptively transferred, interleukin-2-activated NK cells leads to destruction of well-established lung metastases. International Journal of Cancer. Journal International Du Cancer. 105: 512-9. PMID 12712443 DOI: 10.1002/Ijc.11119  0.118
1995 Lunardi-Iskandar Y, Bryant JL, Zeman RA, Lam VH, Samaniego F, Besnier JM, Hermans P, Thierry AR, Gill P, Gallo RC. Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone. Nature. 375: 64-8. PMID 7723844 DOI: 10.1038/375064a0  0.116
1994 Santoro TJ, Bryant JL, Pellicoro J, Klotman ME, Kopp JB, Bruggeman LA, Franks RR, Notkins AL, Klotman PE. Growth failure and AIDS-like cachexia syndrome in HIV-1 transgenic mice. Virology. 201: 147-51. PMID 7909972 DOI: 10.1006/Viro.1994.1276  0.115
2012 Royal W, Zhang L, Guo M, Jones O, Davis H, Bryant JL. Immune activation, viral gene product expression and neurotoxicity in the HIV-1 transgenic rat. Journal of Neuroimmunology. 247: 16-24. PMID 22503372 DOI: 10.1016/j.jneuroim.2012.03.015  0.112
1998 Hermans P, Clumeck N, Picard O, van Vooren JP, Duriez P, Zucman D, Bryant JL, Gill P, Lunardi-Iskandar Y, Gallo RC. AIDS-related Kaposi's sarcoma patients with visceral manifestations. Response to human chorionic gonadotropin preparations. Journal of Human Virology. 1: 82-9. PMID 10195236  0.105
1996 Popescu NC, Zimonjic DB, Leventon-Kriss S, Bryant JL, Lunardi-Iskandar Y, Gallo RC. Deletion and translocation involving chromosome 3 (p14) in two tumorigenic Kaposi's sarcoma cell lines. Journal of the National Cancer Institute. 88: 450-5. PMID 8618237 DOI: 10.1093/Jnci/88.7.450  0.105
2002 Smith MM, Bryant JL. Mind-body and mind-gut connection in inflammatory bowel disease. Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates. 25: 213-7. PMID 12394398  0.095
2012 Jones SC, Bryant JL. Contact Toxicity and Residual Efficacy of Indoxacarb against the European Earwig (Dermaptera: Forficulidae). Insects. 3: 593-600. PMID 26466616 DOI: 10.3390/insects3030593  0.092
2016 Meredith SL, Bryant JL, Babur M, Riddell PW, Behrouzi R, Williams KJ, White A. Irradiation Decreases the Neuroendocrine Biomarker Pro-Opiomelanocortin in Small Cell Lung Cancer Cells In Vitro and In Vivo. Plos One. 11: e0148404. PMID 26848743 DOI: 10.1371/journal.pone.0148404  0.091
2012 Jones SC, Bryant JL. Ineffectiveness of over-the-counter total-release foggers against the bed bug (Heteroptera: Cimicidae). Journal of Economic Entomology. 105: 957-63. PMID 22812136 DOI: 10.1603/EC12037  0.089
2008 Bryant JL. Animal models in virology Source Book of Models For Biomedical Research. 557-563. DOI: 10.1007/978-1-59745-285-4_57  0.089
2007 Oladeinde FO, Kinyua AM, Laditan AA, Michelin R, Bryant JL, Denaro F, Makinde JM, Williams AL, Kennedy AP, Bronner Y. Effect of Cnidoscolus aconitifolius leaf extract on the blood glucose and insulin levels of inbred type 2 diabetic mice. Cellular and Molecular Biology (Noisy-Le-Grand, France). 53: 34-41. PMID 17531147 DOI: 10.1170/T794  0.086
1995 Nannmark U, Johansson BR, Bryant JL, Unger ML, Hokland ME, Goldfarb RH, Basse PH. Microvessel origin and distribution in pulmonary metastases of B16 melanoma: implication for adoptive immunotherapy. Cancer Research. 55: 4627-32. PMID 7553640  0.083
1997 De SK, Wohlenberg CR, Marinos NJ, Doodnauth D, Bryant JL, Notkins AL. Human chorionic gonadotropin hormone prevents wasting syndrome and death in HIV-1 transgenic mice. The Journal of Clinical Investigation. 99: 1484-91. PMID 9119991 DOI: 10.1172/JCI119310  0.082
1996 Friberg DD, Bryant JL, Whiteside TL. Measurements of Natural Killer (NK) Activity and NK-Cell Quantification Methods (San Diego, Calif.). 9: 316-26. PMID 8812685 DOI: 10.1006/meth.1996.0037  0.081
1995 Lunardi-Iskandar Y, Gill P, Lam VH, Zeman RA, Michaels F, Mann DL, Reitz MS, Kaplan M, Berneman ZN, Carter D, Bryant JL, Gallo RC. Isolation and characterization of an immortal neoplastic cell line (KS Y-1) from AIDS-associated Kaposi's sarcoma Journal of the National Cancer Institute. 87: 974-981. PMID 7629884 DOI: 10.1093/Jnci/87.13.974  0.081
2012 Izraely S, Sagi-Assif O, Klein A, Meshel T, Tsarfaty G, Pasmanik-Chor M, Nahmias C, Couraud PO, Ateh E, Bryant JL, Hoon DS, Witz IP. The metastatic microenvironment: brain-residing melanoma metastasis and dormant micrometastasis. International Journal of Cancer. Journal International Du Cancer. 131: 1071-82. PMID 22025079 DOI: 10.1002/ijc.27324  0.08
1983 Bryant JL, Stills HF, Lentsch RH, Middleton CC. Campylobacter jejuni isolated from patas monkeys with diarrhea. Laboratory Animal Science. 33: 303-5. PMID 6876739  0.076
2013 Jazaeri AA, Shibata E, Park J, Bryant JL, Conaway MR, Modesitt SC, Smith PG, Milhollen MA, Berger AJ, Dutta A. Overcoming platinum resistance in preclinical models of ovarian cancer using the neddylation inhibitor MLN4924. Molecular Cancer Therapeutics. 12: 1958-67. PMID 23939375 DOI: 10.1158/1535-7163.Mct-12-1028  0.075
1996 Flamand L, Zeman RA, Bryant JL, Lunardi-Iskandar Y, Gallo RC. Absence of human herpesvirus 8 DNA sequences in neoplastic Kaposi's sarcoma cell lines. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association. 13: 194-7. PMID 8862285 DOI: 10.1097/00042560-199610010-00011  0.072
1976 Bryant JL, Paulson AS. An extension of Tukey's method of multiple comparisons to experimental designs with random concomitant variables Biometrika. 63: 631-638.  0.071
1999 Bryant JL, Mio W. Transversality in generalized manifolds Topology and Its Applications. 94: 7-12.  0.071
1984 Bryant JL, King J. DNA injection proteins are targets of acridine-sensitized photoinactivation of bacteriophage P22. Journal of Molecular Biology. 180: 837-63. PMID 6335533 DOI: 10.1016/0022-2836(84)90260-2  0.07
2013 Stovold R, Meredith SL, Bryant JL, Babur M, Williams KJ, Dean EJ, Dive C, Blackhall FH, White A. Neuroendocrine and epithelial phenotypes in small-cell lung cancer: implications for metastasis and survival in patients. British Journal of Cancer. 108: 1704-11. PMID 23519056 DOI: 10.1038/bjc.2013.112  0.069
1986 Tate RL, Bryant JL. Parameter Sensitivity for Discriminant Analysis. Multivariate Behavioral Research. 21: 411-27. PMID 26828219 DOI: 10.1207/s15327906mbr2104_3  0.069
2003 Goldkrand JW, Hough TM, Lentz SU, Clements SP, Bryant JL, Hodges JA. Comparison of the amniotic fluid index with gray-scale and color Doppler ultrasound. The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 13: 318-22. PMID 12916682 DOI: 10.1080/jmf.13.5.318.322  0.061
2000 Bryant JL, Mio W. Embeddings in generalized manifolds Transactions of the American Mathematical Society. 352: 1131-1147. DOI: 10.1090/S0002-9947-99-02531-3  0.061
2009 Xu M, Xu X, Cao G, Pan Y, Jones O, Bryant JL, Anthony D, He H, Yan G, Zhang C. The liquid crystalline in normal renal development amplifies the comprehension for Anderson-Fabry disease Molecular Crystals and Liquid Crystals. 508: 52-66. DOI: 10.1080/15421400903058437  0.061
2011 Xu M, Jones OD, Zheng S, Yanfei L, Yan G, Pan Y, Davis HG, Anthony DD, Xu Y, Bryant JL, Xu X. Cytoplasmic accumulation of liquid-crystal like droplets in post-infection sputum generated by gram-positive bacteria Molecular Crystals and Liquid Crystals. 547: 173-180. DOI: 10.1080/15421406.2011.572045  0.061
2001 Bryant JL. A survey of recent results on generalized manifolds Topology and Its Applications. 113: 13-22.  0.059
1997 Yong FH, Taylor JM, Bryant JL, Chmiel JS, Gange SJ, Hoover D. Dependence of the hazard of AIDS on markers. Aids (London, England). 11: 217-28. PMID 9030370 DOI: 10.1097/00002030-199702000-00013  0.057
2003 Davis DD, Bryant JL. INFLUENCE AT A DISTANCE: LEADERSHIP IN GLOBAL VIRTUAL TEAMS Advances in Global Leadership. 3: 303-340. DOI: 10.1016/S1535-1203(02)03015-0  0.055
1998 Lunardi-Iskandar Y, Bryant JL, Blattner WA, Hung CL, Flamand L, Gill P, Hermans P, Birken S, Gallo RC. Effects of a urinary factor from women in early pregnancy on HIV-1, SIV and associated disease. Nature Medicine. 4: 428-34. PMID 9546788 DOI: 10.1038/nm0498-428  0.055
1978 Bryant JL, Lacher RC. A Hopf-like invariant for mappings between odd-dimensional manifolds General Topology and Its Applications. 8: 47-62. DOI: 10.1016/0016-660X(78)90016-8  0.053
2007 Royal W, Wang H, Jones O, Tran H, Bryant JL. A vitamin A deficient diet enhances proinflammatory cytokine, Mu opioid receptor, and HIV-1 expression in the HIV-1 transgenic rat. Journal of Neuroimmunology. 185: 29-36. PMID 17289162 DOI: 10.1016/j.jneuroim.2007.01.001  0.052
1999 Lunardi-Iskandar Y, Wernert N, Cong TH, Samnang S, Bryant JL, Vandenbunder B, Stéhelin D. Neoplastic AIDS-associated Kaposi's sarcoma cell line KSY-1 cannot transdifferentiate into capillaries. Journal of Human Virology. 2: 315-7. PMID 10551738  0.051
2003 Ray PE, Liu XH, Robinson LR, Reid W, Xu L, Owens JW, Jones OD, Denaro F, Davis HG, Bryant JL. A novel HIV-1 transgenic rat model of childhood HIV-1-associated nephropathy. Kidney International. 63: 2242-53. PMID 12753314 DOI: 10.1046/j.1523-1755.2003.00028.x  0.051
2002 Pati S, Pelser CB, Dufraine J, Bryant JL, Reitz MS, Weichold FF. Antitumorigenic effects of HIV protease inhibitor ritonavir: inhibition of Kaposi sarcoma. Blood. 99: 3771-9. PMID 11986235 DOI: 10.1182/blood.V99.10.3771  0.051
1996 Shi M, Taylor JM, Currier RJ, Tang H, Hoover DR, Chmiel JS, Bryant JL. Replacing time since human immunodeficiency virus infection by marker values in predicting residual time to acquired immunodeficiency syndrome diagnosis. Multicenter AIDS Cohort Study. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association. 12: 309-16. PMID 8673537 DOI: 10.1097/00042560-199607000-00013  0.05
1980 Bryant JL, Bruvold NT. Multiple comparison procedures in the analysis of covariance Journal of the American Statistical Association. 75: 874-880. DOI: 10.1080/01621459.1980.10477566  0.049
2014 Bryant JL, Meredith SL, Williams KJ, White A. Targeting hypoxia in the treatment of small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 86: 126-32. PMID 25201720 DOI: 10.1016/j.lungcan.2014.08.003  0.049
2004 Izevbigie EB, Bryant JL, Walker A. A novel natural inhibitor of extracellular signal-regulated kinases and human breast cancer cell growth. Experimental Biology and Medicine (Maywood, N.J.). 229: 163-9. PMID 14734795  0.048
2006 Fletcher CA, Liao Z, Adams RJ, Carter DL, Jones OD, Davis HG, Bryant JL, Hildreth JE. Characterization of an anti-lymphocyte function-associated antigen-1 antibody in a simian immunodeficiency virus-pig-tailed macaque (Macaca nemestrina) model. Comparative Medicine. 56: 23-30. PMID 16521856  0.046
1990 Bryant JL. Triangulation and general position of PL diagrams Topology and Its Applications. 34: 211-233. DOI: 10.1016/0166-8641(90)90039-5  0.045
2011 Xu X, Xu M, Jones OD, Chen X, Yanfei L, Yan G, Pan Y, Davis HG, Xu Y, Bryant JL, Zheng S, Anthony DD. Liquid crystal in lung development and chicken embryogenesis Molecular Crystals and Liquid Crystals. 547: 164-172. DOI: 10.1080/15421406.2011.572042  0.045
1999 Reid WC, Carmichael KP, Srinivas S, Bryant JL. Pathologic changes associated with use of tribromoethanol (avertin) in the Sprague Dawley rat. Laboratory Animal Science. 49: 665-7. PMID 10638506  0.045
1983 Bryant JL, Paulson AS. Estimation of Mixing Proportions Via Distance Between Characteristic Functions Communications in Statistics - Theory and Methods. 12: 1009-1029. DOI: 10.1080/03610928308828512  0.045
1999 Weichold FF, Bryant JL, Pati S, Barabitskaya O, Gallo RC, Reitz MS. HIV-1 protease inhibitor ritonavir modulates susceptibility to apoptosis of uninfected T cells. Journal of Human Virology. 2: 261-9. PMID 10551732  0.044
1985 Bryant JL, Fox GE. Some comments on a class of simultaneous inference procedures in ancova Communications in Statistics - Theory and Methods. 14: 2489-2493. DOI: 10.1080/03610928508829057  0.041
1987 Bryant JL. Homogeneous ENR's Topology and Its Applications. 27: 301-306. DOI: 10.1016/0166-8641(87)90094-0  0.041
1991 Logan TF, Kaplan SS, Bryant JL, Ernstoff MS, Krause JR, Kirkwood JM. Granulocytopenia in cancer patients treated in a phase I trial with recombinant human tumor necrosis factor. Journal of Immunotherapy : Official Journal of the Society For Biological Therapy. 10: 84-95. PMID 1675121  0.04
1994 Cook PR, Bryant JL, Davis WE, Benke TT, Rapoport AS. Systemic reactions to immunotherapy: the American Academy of Otolaryngic Allergy morbidity and mortality survey. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 110: 487-93. PMID 8208561  0.038
1993 Birch LL, McPhee LS, Bryant JL, Johnson SL. Children's lunch intake: effects of midmorning snacks varying in energy density and fat content. Appetite. 20: 83-94. PMID 8507070 DOI: 10.1006/appe.1993.1011  0.038
1995 Rosenbloom AJ, Pinsky MR, Bryant JL, Shin A, Tran T, Whiteside T. Leukocyte activation in the peripheral blood of patients with cirrhosis of the liver and SIRS. Correlation with serum interleukin-6 levels and organ dysfunction. Jama. 274: 58-65. PMID 7540697 DOI: 10.1001/jama.1995.03530010072037  0.038
2006 Young Lee S, Cisar JO, Bryant JL, Eckhaus MA, Sandberg AL. Resistance of Streptococcus gordonii to polymorphonuclear leukocyte killing is a potential virulence determinant of infective endocarditis. Infection and Immunity. 74: 3148-55. PMID 16714542 DOI: 10.1128/IAI.00087-06  0.037
2007 Gilliam BL, Heredia A, Devico A, Le N, Bamba D, Bryant JL, Pauza CD, Redfield RR. Rapamycin reduces CCR5 mRNA levels in macaques: potential applications in HIV-1 prevention and treatment. Aids (London, England). 21: 2108-10. PMID 17885304 DOI: 10.1097/QAD.0b013e3282f02a4f  0.037
2007 Cairo C, Hebbeler AM, Propp N, Bryant JL, Colizzi V, Pauza CD. Innate-like gammadelta T cell responses to mycobacterium Bacille Calmette-Guerin using the public V gamma 2 repertoire in Macaca fascicularis. Tuberculosis (Edinburgh, Scotland). 87: 373-83. PMID 17292671 DOI: 10.1016/j.tube.2006.12.004  0.037
2012 Yang DJ, Kong FL, Oka T, Bryant JL. Molecular imaging kits for hexosamine biosynthetic pathway in oncology. Current Medicinal Chemistry. 19: 3310-4. PMID 22664248 DOI: 10.2174/092986712801215900  0.036
2003 Kandasamy K, Srinivasula SM, Alnemri ES, Thompson CB, Korsmeyer SJ, Bryant JL, Srivastava RK. Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release. Cancer Research. 63: 1712-21. PMID 12670926  0.036
1989 Yang NY, Bryant JL, Shih JW. Development of a direct-binding enzyme-linked immunosorbent assay as an alternate assay for anti-hepatitis B core. Vox Sanguinis. 57: 49-54. PMID 2800466  0.035
1995 Jinneman KC, Trost PA, Hill WE, Weagant SD, Bryant JL, Kaysner CA, Wekell MM. Comparison of template preparation methods from foods for amplification of escherichia coli O157 shiga-Like toxins type i and II DNA by multiplex polymerase chain reaction Journal of Food Protection. 58: 722-726.  0.035
2001 Bryant JL, Brooks TL, Schmidt B, Mostow EN. Reliability of wound measuring techniques in an outpatient wound center. Ostomy/Wound Management. 47: 44-51. PMID 11890088  0.033
1992 Bryant JL, Mehta P, Von der Porten A, Mehta JL. Co-purification of 130 kD nitric oxide synthase and a 22 kD link protein from human neutrophils. Biochemical and Biophysical Research Communications. 189: 558-64. PMID 1280429 DOI: 10.1016/0006-291X(92)91594-G  0.032
2002 Bryant JL, Kirby P. Splitting manifold approximate fibrations Topology. 41: 1041-1050. DOI: 10.1016/S0040-9383(01)00028-3  0.031
1985 Wells CE, Bryant JL. An adaptive estimation procedure using the laplace transformation Iie Transactions (Institute of Industrial Engineers). 17: 242-251. DOI: 10.1080/07408178508975299  0.03
1978 Bryant JL, Paulson AS. GOODNESS-OF-FIT AND EMPIRICAL CHARACTERISTIC FUNCTIONS Modeling and Simulation, Proceedings of the Annual Pittsburgh Conference. 9: 997-1002.  0.029
2013 Bryant JL. Talking "religious, superstitious nonsense" in the classroom: When do teachers' disparaging comments about religion run afoul of the establishment clause? Southern California Law Review. 86: 1343-1388.  0.029
1975 Bryant JL, Lacher RC. Embeddings with mapping cylinder neighborhoods Topology. 14: 191-201. DOI: 10.1016/0040-9383(75)90027-0  0.029
2014 Lowe HI, Facey CO, Toyang NJ, Bryant JL. Specific RSK kinase inhibition by dibenzyl trisulfide and implication for therapeutic treatment of cancer. Anticancer Research. 34: 1637-41. PMID 24692692  0.029
1995 Mehta JL, Bryant JL, Mehta P. Reduction of nitric oxide synthase activity in human neutrophils by oxidized low-density lipoproteins. Reversal of the effect of oxidized low-density lipoproteins by high-density lipoproteins and L-arginine. Biochemical Pharmacology. 50: 1181-5. PMID 7488232 DOI: 10.1016/0006-2952(95)00254-W  0.028
1985 Wells CE, Bryant JL. Reliability Characteristics of a Markov System With a Mission of Random Duration Ieee Transactions On Reliability. 393-396. DOI: 10.1109/TR.1985.5222204  0.028
2010 Jazaeri AA, Ferriss JS, Bryant JL, Dalton MS, Dutta A. Evaluation of EVI1 and EVI1s (Delta324) as potential therapeutic targets in ovarian cancer. Gynecologic Oncology. 118: 189-95. PMID 20462630 DOI: 10.1016/J.Ygyno.2010.04.007  0.027
2008 Royal W, Bryant JL. Retinoids and opioids: Factors in the development of HIV-related neurological disease American Journal of Infectious Diseases. 4: 140-146.  0.027
2003 Yang DJ, Kim CG, Schechter NR, Azhdarinia A, Yu DF, Oh CS, Bryant JL, Won JJ, Kim EE, Podoloff DA. Imaging with 99mTc ECDG targeted at the multifunctional glucose transport system: feasibility study with rodents. Radiology. 226: 465-73. PMID 12563141 DOI: 10.1148/radiol.2262011811  0.027
2010 Davis DD, Bryant JL. Leader-member exchange, trust, and performance in national science foundation industry/university cooperative research centers Journal of Technology Transfer. 35: 511-526. DOI: 10.1007/s10961-009-9144-0  0.026
2012 Bryant JL, Britson J, Balko JM, Willian M, Timmons R, Frolov A, Black EP. A microRNA gene expression signature predicts response to erlotinib in epithelial cancer cell lines and targets EMT. British Journal of Cancer. 106: 148-56. PMID 22045191 DOI: 10.1038/bjc.2011.465  0.026
1991 Bryant JL, Boyd EL, Wittich DJ, Hunter JO, Wachtel TJ, Bostom A, Worrell AM, Reisman RE, Jewett DL, Fein G, Greenberg MR. Provocation testing and food sensitivity [1] New England Journal of Medicine. 325: 1171-1174. PMID 1891028  0.025
1999 Bryant JL, Mio W. Embeddings of homology manifolds in codimension ≥ 3 Topology. 38: 811-821.  0.023
2010 Calver LA, Downes MA, Page CB, Bryant JL, Isbister GK. The impact of a standardised intramuscular sedation protocol for acute behavioural disturbance in the emergency department. Bmc Emergency Medicine. 10: 14. PMID 20584282 DOI: 10.1186/1471-227X-10-14  0.023
1985 Wells CE, Bryant JL. Optimal design of standby redundant components for a system which has a mission of random duration Iie Transactions (Institute of Industrial Engineers). 17: 302-307. DOI: 10.1080/07408178508975307  0.023
1994 Bryant JL. Kaposi's sarcoma, vascular permeability, and scientific integrity. Jama. 272: 921; author reply 92. PMID 8084056 DOI: 10.1001/jama.1994.03520120026022  0.023
2001 Goldkrand JW, Pettigrew C, Lentz SU, Clements SP, Bryant JL, Hodges J. Volumetric umbilical artery blood flow: comparison of the normal versus the single umbilical artery cord. The Journal of Maternal-Fetal Medicine. 10: 116-21. PMID 11392591 DOI: 10.1080/714052729  0.022
2005 Carter GL, Lewin TJ, Stoney C, Whyte IM, Bryant JL. Clinical management for hospital-treated deliberate self-poisoning: comparisons between patients with major depression and borderline personality disorder. The Australian and New Zealand Journal of Psychiatry. 39: 266-73. PMID 15777364 DOI: 10.1111/j.1440-1614.2005.01564.x  0.022
1995 Bryant JL, Hosangadi P, Beachy RN. The beta-conglycinins of soybean remain assembled in a 7S conformation while undergoing proteolytic cleavage during germination and early seedling growth Plant and Cell Physiology. 36: 1059-1065.  0.021
1996 Fornadley JA, Corey JP, Osguthorpe JD, Powell JP, Emanuel IA, Boyles JH, Watson TA, Hurst DS, Bryant JL, Pershall KE, Renfro BL. Allergic rhinitis: clinical practice guideline. Committee on Practice Standards, American Academy of Otolaryngic Allergy. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 115: 115-22. PMID 8758640  0.021
1995 Lunardi-Iskandar Y, Zeman RA, Lam VH, Samaniego F, Thierry AR, Gallo RC, Bryant JL, Besnier JM, Hermans P, Gill P. Kaposi's sarcoma in pregnant women [12] Nature. 377: 22.  0.02
1993 Yang BC, Saldeen TG, Bryant JL, Nichols WW, Mehta JL. Long-term dietary fish oil supplementation protects against ischemia-reperfusion-induced myocardial dysfunction in isolated rat hearts. American Heart Journal. 126: 1287-92. PMID 8249783 DOI: 10.1016/0002-8703(93)90524-D  0.019
1985 Wells CE, Bryant JL. Optimal preventive maintenance policies for systems with missions of random duration Iie Transactions (Institute of Industrial Engineers). 17: 338-345. DOI: 10.1080/07408178508975313  0.018
2009 Downes MA, Healy P, Page CB, Bryant JL, Isbister GK. Structured team approach to the agitated patient in the emergency department. Emergency Medicine Australasia : Ema. 21: 196-202. PMID 19527279 DOI: 10.1111/j.1742-6723.2009.01182.x  0.018
1995 Weagant SD, Bryant JL, Jinneman KG. An improved rapid technique for isolation of Escherichia coli O157:H7 from foods Journal of Food Protection. 58: 7-12.  0.018
2002 Carter GL, Clover KA, Bryant JL, Whyte IM. Can the Edinburgh Risk of Repetition Scale predict repetition of deliberate self-poisoning in an Australian clinical setting? Suicide & Life-Threatening Behavior. 32: 230-9. PMID 12374470 DOI: 10.1521/suli.32.3.230.22175  0.017
2004 Brannon HD, Malone MR, Rickards AR, Wood WD, Edgeman JR, Bryant JL. Maximizing fracture conductivity with proppant partial monolayers: Theoretical curiosity or highly productive reality? Proceedings - Spe Annual Technical Conference and Exhibition. 3569-3591.  0.017
2001 Patello G, Ross O'Neil L, Bryant JL. Establishing a lactation support program at Pacific Northwest National Laboratory Chemical Health and Safety. 8: 9-11. DOI: 10.1016/S1074-9098(01)00187-3  0.017
1997 Thierry AR, Rabinovich P, Peng B, Mahan LC, Bryant JL, Gallo RC. Characterization of liposome-mediated gene delivery: expression, stability and pharmacokinetics of plasmid DNA. Gene Therapy. 4: 226-37. PMID 9135736 DOI: 10.1038/Sj.Gt.3300350  0.017
1995 Johnson JM, Weagant SD, Jinneman KC, Bryant JL. Use of pulsed-field gel electrophoresis for epidemiological study of Escherichia coli O157:H7 during a food-borne outbreak. Applied and Environmental Microbiology. 61: 2806-8. PMID 7618896  0.016
2011 Cedeno-Laurent F, Gómez-Flores M, Mendez N, Ancer-Rodríguez J, Bryant JL, Gaspari AA, Trujillo JR. New insights into HIV-1-primary skin disorders. Journal of the International Aids Society. 14: 5. PMID 21261982 DOI: 10.1186/1758-2652-14-5  0.016
1995 Anderson SJ, Costantino JP, Brown AM, Bryant JL, Cronin WM, Dignam JJ, Jones JM, Rockette HE, Wieand S. Breast cancer trials on trial: a case of conflicting ethical interests. Cancer. 76: 1294-5. PMID 8630911 DOI: 10.1002/1097-0142(19951001)76:7<1294::AID-CNCR2820760729>3.0.CO;2-U  0.015
1974 Bryant JL, Hollingsworth JG. Manifold factors that are manifold quotients Topology. 13: 19-24. DOI: 10.1016/0040-9383(74)90035-4  0.014
2004 Waterman PM, Kitabwalla M, Hatfield GS, Evans PS, Lu Y, Tikhonov I, Bryant JL, Pauza CD. Effects of virus burden and chemokine expression on immunity to SHIV in nonhuman primates. Viral Immunology. 17: 545-57. PMID 15671751 DOI: 10.1089/vim.2004.17.545  0.014
2003 Bryant JL, Beinlich NR. How to start a nurse-managed foot care clinic. Orthopedic Nursing. 22: 437-41. PMID 14705474  0.014
2002 Yang DJ, Kim KD, Schechter NR, Yu DF, Wu P, Azhdarinia A, Roach JS, Kalimi SK, Ozaki K, Fogler WE, Bryant JL, Herbst R, Abbruzzes J, Kim EE, Podoloff DA. Assessment of antiangiogenic effect using 99mTc-EC-endostatin. Cancer Biotherapy & Radiopharmaceuticals. 17: 233-45. PMID 12030117 DOI: 10.1089/108497802753773856  0.013
2000 Goldkrand JW, Moore DH, Lentz SU, Clements SP, Turner AD, Bryant JL. Volumetric flow in the umbilical artery: normative data. The Journal of Maternal-Fetal Medicine. 9: 224-8. PMID 11048833 DOI: 10.1002/1520-6661(200007/08)9:4<224::AID-MFM7>3.0.CO;2-W  0.012
1994 Bryant JL. PA program benefits health care in West Virginia. The West Virginia Medical Journal. 90: 290. PMID 7916517  0.012
1990 Bryant JL, Lacher RC. Molecular weight dependence in Flory's theory of crystallization of copolymers The Journal of Chemical Physics. 92: 3977-3979.  0.011
1999 Bryant JL. Pediatric allergy Current Opinion in Otolaryngology and Head and Neck Surgery. 7: 379-382. DOI: 10.1097/00020840-199912000-00017  0.011
2015 Borello LJ, Lichter R, Pearson W, Bryant JL. International status of women in the chemical sciences Advancing Women in Science: An International Perspective. 131-159. DOI: 10.1007/978-3-319-08629-3_5  0.01
2006 Carter GL, Safranko I, Lewin TJ, Whyte IM, Bryant JL. Psychiatric hospitalization after deliberate self-poisoning. Suicide & Life-Threatening Behavior. 36: 213-22. PMID 16704325 DOI: 10.1521/suli.2006.36.2.213  0.01
1999 Bryant JL, Beinlich NR. Foot care: focus on the elderly. Orthopedic Nursing. 18: 53-60. PMID 11062615  0.01
1999 Bryant JL, Turkoski BB. Relieving intermittent claudication: a nursing approach. Journal of Vascular Nursing : Official Publication of the Society For Peripheral Vascular Nursing. 17: 81-5. PMID 10818885  0.01
1995 Bryant JL. Preventive foot care program: a nursing perspective. Ostomy/Wound Management. 41: 28-30, 32-4. PMID 7598781  0.01
1994 Weagant SD, Bryant JL, Bark DH. Survival of Escherichia coli O157:H7 in mayonnaise and mayonnaise-based sauces at room and refrigerated temperatures Journal of Food Protection. 57: 629-631.  0.01
1988 Bryant JL, Pacheco PS. K-i obstructions to factoring an open manifold Topology and Its Applications. 29: 107-139. DOI: 10.1016/0166-8641(88)90070-3  0.01
1988 Lacher RC, Bryant JL. On the amorphous structure of ethylene-1-alkene copolymers Macromolecules. 21: 1183-1184.  0.01
1986 Lacher RC, Bryant JL, Howard LN, Sumners DW. Linking phenomena in the amorphous phase of semicrystalline polymers Macromolecules. 19: 2639-2643.  0.01
1982 Bryant JL, Petty ME. Splitting manifolds as M × R where M has a k-fold end structure Topology and Its Applications. 14: 87-104. DOI: 10.1016/0166-8641(82)90049-9  0.01
1970 Bryant JL, Seebeck CL. Locally nice embeddings in codimension three Quarterly Journal of Mathematics. 21: 265-272. DOI: 10.1093/qmath/21.3.265  0.01
1968 Bryant JL, Seebeck CL. Locally nice embeddings of polyhedra Quarterly Journal of Mathematics. 19: 257-274. DOI: 10.1093/qmath/19.1.257  0.01
Hide low-probability matches.